Steven Cohen’s Bicara Therapeutics BCAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$11.7M Buy
+627,108
New +$15.7M 0.01% 1259
2025
Q4
– Sell
-30,138
Closed -$476K – 4242
2025
Q3
$476K Sell
30,138
-186,698
-86% -$2.09M ﹤0.01% 1942
2025
Q2
$2.01M Buy
+216,836
New +$2.58M ﹤0.01% 1299
2024
Q4
– Sell
-371,962
Closed -$9.47M – 2543
2024
Q3
$9.47M Buy
+371,962
New +$9.49M 0.02% 664

Other funds holding BCAX

Steven Cohen's BCAX Position: Q3 2026 in Review

Steven Cohen opened a new position in Bicara Therapeutics (BCAX) in Q3 2026: 627,108 shares worth $11.7M. The stake represents 0.01% of the portfolio and ranks #1259 among its holdings. This is a return to the name: Steven Cohen previously reported a position in BCAX as recently as Q3 2025.

Steven Cohen first reported a position in BCAX in Q3 2024 and has held it in 4 quarters since. 167 funds tracked by Wall St. Rank hold BCAX as of Q3 2026.

  • Steven Cohen held 627,108 shares of Bicara Therapeutics worth $11.7M as of Q3 2026.
  • Bicara Therapeutics was a new Steven Cohen position in Q3 2026.
  • Bicara Therapeutics made up 0.01% of Steven Cohen's portfolio in Q3 2026, its #1259 holding.
  • Steven Cohen first reported a position in Bicara Therapeutics in Q3 2024 and has held it in 4 quarters since.
  • 167 funds tracked by Wall St. Rank held Bicara Therapeutics as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.